News

News
JNJ Press releases

Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
Partner news

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story
JNJ Press releases

Johnson & Johnson Innovation announces extension of JJIPO @ QUT in collaboration with Queensland State Government to further boost life-science innovation in Queensland

Read full story
Partner news

Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen

Read full story
Partner news

Carrot Inc. Raises $25 Million to Commercialize Pivot, the Company's Digital Health Solution for Smoking Cessation

Read full story
Partner news

Touchlight announces collaboration with Janssen Biotech

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches Champions of Science Storytelling Challenge – Latin America & Caribbean Edition

Read full story
Partner news

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

Read full story
In the media

New Head of Johnson & Johnson Innovation lends advice to budding startups with Sir Harpal Kumar

Read full story
In the media

Check Out Europe’s Hottest Pitching Event for Startups!

Read full story
Partner news

Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen

Read full story
JNJ Press releases

Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection

Read full story
In the media

The 7 Best Biotech Startup Competitions in Europe

Read full story
Partner news

BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

Read full story
Partner news

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding

Read full story